Mayank Dalakoti

1.9k total citations · 1 hit paper
34 papers, 258 citations indexed

About

Mayank Dalakoti is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mayank Dalakoti has authored 34 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mayank Dalakoti's work include Cardiac Imaging and Diagnostics (7 papers), Cardiovascular Function and Risk Factors (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Mayank Dalakoti is often cited by papers focused on Cardiac Imaging and Diagnostics (7 papers), Cardiovascular Function and Risk Factors (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Mayank Dalakoti collaborates with scholars based in Singapore, United Kingdom and United States. Mayank Dalakoti's co-authors include Benjamin Yong‐Qiang Tan, Leonard L.L. Yeo, Mark Y. Chan, Ching‐Hui Sia, Pipin Kojodjojo, Vijay K. Sharma, Yao Neng Teo, Pei Chia Eng, Yao Hao Teo and Roger Foo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Diabetes Care.

In The Last Decade

Mayank Dalakoti

31 papers receiving 252 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials

2025 39 citations Yao Hao Teo, Yao Neng Teo et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mayank Dalakoti Singapore	11	140	42	39	35	27	34	258
Ilya Karagodin United States	6	131 0.9×	56 1.3×	49 1.3×	43 1.2×	27 1.0×	20	253
Nicoletta Musacchio Italy	9	78 0.6×	185 4.4×	48 1.2×	61 1.7×	48 1.8×	22	343
Chia‐Wen Hsiao United States	8	38 0.3×	29 0.7×	37 0.9×	17 0.5×	79 2.9×	13	287
Mattheus Ramsis United States	7	239 1.7×	21 0.5×	41 1.1×	50 1.4×	71 2.6×	14	334
Bochra Zareini Denmark	9	127 0.9×	89 2.1×	20 0.5×	18 0.5×	33 1.2×	29	286
Sara Salerni Italy	5	163 1.2×	18 0.4×	39 1.0×	9 0.3×	29 1.1×	6	250
Bruno Pavy France	10	274 2.0×	18 0.4×	32 0.8×	43 1.2×	46 1.7×	34	346
Giacomo Faden Italy	9	220 1.6×	64 1.5×	26 0.7×	97 2.8×	46 1.7×	16	293
Chanavuth Kanitsoraphan United States	13	346 2.5×	33 0.8×	55 1.4×	27 0.8×	66 2.4×	55	490
Per Torger Skretteberg Norway	13	326 2.3×	27 0.6×	30 0.8×	35 1.0×	27 1.0×	23	413

Countries citing papers authored by Mayank Dalakoti

Since Specialization

Citations

This map shows the geographic impact of Mayank Dalakoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayank Dalakoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayank Dalakoti more than expected).

Fields of papers citing papers by Mayank Dalakoti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayank Dalakoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayank Dalakoti. The network helps show where Mayank Dalakoti may publish in the future.

Co-authorship network of co-authors of Mayank Dalakoti

This figure shows the co-authorship network connecting the top 25 collaborators of Mayank Dalakoti. A scholar is included among the top collaborators of Mayank Dalakoti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayank Dalakoti. Mayank Dalakoti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Ling Jie, et al.. (2025). Global prevalence of myocardial fibrosis among individuals with cardiometabolic conditions: a systematic review and meta-analysis. European Journal of Preventive Cardiology. 32(12). 1077–1091.

Choi, Ellie, Phillip Phan, Liang Shen, et al.. (2025). Protocol for a double-blinded randomised controlled trial and process evaluation of a digital psychotherapeutic app in Singapore to improve symptom burden in patients with dermatological problems. BMJ Open. 15(7). e098266–e098266. 1 indexed citations

Dalakoti, Mayank, Redha Boubertakh, Jennifer Bryant, et al.. (2025). Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial. Nature Communications. 16(1). 6981–6981. 2 indexed citations

Teo, Yao Hao, Yao Neng Teo, Mark Y. Chan, et al.. (2025). Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care. 48(2). 292–300. 39 indexed citations breakdown →

Sun, Lijuan, Simon Y. Foo, Melvin Khee‐Shing Leow, et al.. (2025). Perspectives on whole body and tissue-specific metabolic flexibility and implications in cardiometabolic diseases. Europe PMC (PubMed Central). 6(9). 102354–102354.

Tyebally, Sara, Ching‐Hui Sia, Daniel Chen, et al.. (2024). The intersection of heart failure and cancer in women: a review. Frontiers in Cardiovascular Medicine. 11. 1276141–1276141. 1 indexed citations

Dalakoti, Mayank, Shaun Loong, Poay Huan Loh, et al.. (2024). Incorporating AI into cardiovascular diseases prevention–insights from Singapore. The Lancet Regional Health - Western Pacific. 48. 101102–101102. 14 indexed citations

Lee, Michelle H., Sonia Baig, Liang Shen, et al.. (2024). Performance of the 1 h oral glucose tolerance test in predicting type 2 diabetes and association with impaired β-cell function in Asians: a national prospective cohort study. The Lancet Regional Health - Western Pacific. 54. 101278–101278. 1 indexed citations

Koh, Jin Hean, Lincoln Kai En Lim, Ying Kiat Tan, et al.. (2024). Assessment of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging in Ischemic Stroke Patients Without Atrial Fibrillation: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 13(17). e033059–e033059. 3 indexed citations

10.

Gupta, Kartik, Bharat Rawlley, Chelsea Meloche, et al.. (2024). Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference. Current Atherosclerosis Reports. 26(8). 367–381. 4 indexed citations

11.

Dalakoti, Mayank & Salim S. Virani. (2024). Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets. SHILAP Revista de lepidopterología. 19. 100720–100720. 2 indexed citations

12.

Ang, Chin‐Siang, et al.. (2024). Advancing health coaching: A comparative study of large language model and health coaches. Artificial Intelligence in Medicine. 157. 103004–103004. 10 indexed citations

13.

Lim, Daniel Yan Zheng, Hankun Wang, Gerald Gui Ren Sng, et al.. (2023). Outcomes of Investigating T Wave Inversion With Echocardiography in an Unselected Young Male Preparticipation Cohort. Journal of the American Heart Association. 12(7). e026975–e026975. 2 indexed citations

14.

Ng, Cheng Han, Yip Han Chin, Phoebe Wen Lin Tay, et al.. (2022). Can Glucose-Lowering Medications Improve Outcomes in Non-Diabetic Heart Failure Patients? A Bayesian Network Meta-Analysis. ESC Heart Failure. 9(2). 1338–1350. 12 indexed citations

15.

Lim, Daniel Yan Zheng, Gerald Gui Ren Sng, Hankun Wang, et al.. (2021). Machine learning versus classic electrocardiographic criteria for the detection of echocardiographic left ventricular hypertrophy in a pre-participation cohort. Kardiologia Polska. 79(6). 654–661. 11 indexed citations

16.

Li, Tony, Leonard L.L. Yeo, Jamie Sin Ying Ho, et al.. (2021). Association of Global Cardiac Calcification with Atrial Fibrillation and Recurrent Stroke in Patients with Embolic Stroke of Undetermined Source. Journal of the American Society of Echocardiography. 34(10). 1056–1066. 5 indexed citations

17.

Tan, Benjamin Yong‐Qiang, Jamie Sin Ying Ho, Ching‐Hui Sia, et al.. (2020). Left Atrial Volume Index Predicts New-Onset Atrial Fibrillation and Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source. Cerebrovascular Diseases. 49(3). 285–291. 30 indexed citations

18.

Tan, Benjamin Yong‐Qiang, Jinghao Nicholas Ngiam, Bernard Chan, et al.. (2019). Association between Bilateral Infarcts Pattern and Detection of Occult Atrial Fibrillation in Embolic Stroke of Undetermined Source (ESUS) Patients with Insertable Cardiac Monitor (ICM). Journal of Stroke and Cerebrovascular Diseases. 28(9). 2448–2452. 17 indexed citations

19.

Dalakoti, Mayank, et al.. (2019). Electrocardiography findings and clinical presentation in Ebstein’s anomaly. Singapore Medical Journal. 60(11). 560–565. 1 indexed citations

20.

Wang, Pei, Philip Yap, Gerald Choon‐Huat Koh, et al.. (2016). Quality of life and related factors of nursing home residents in Singapore. Health and Quality of Life Outcomes. 14(1). 112–112. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact